Artificial light at night (ALAN) can cause circadian disruption and result in adverse behavioral and ecological effects in free‐living birds, but studies on captive pet birds as companion animals have been infrequent. We studied the effects of exposure to bright ALAN on body mass, melatonin sulfate levels, reproduction and disease severity in Australian budgerigars (Melopsittacus undulatus) kept in captivity. During the experiment, birds were kept under outdoor temperature, humidity and natural photoperiod from September to December. A total of 48 birds were equally split into 4 groups (6 mating pairs each) and concurrently exposed to ALAN of 200 lux with different duration (0, 30, 60 and 90 min). Monthly observations were recorded for all dependent parameters. ALAN exposure increased mass gain and suppressed melatonin levels in a dose‐dependent manner, especially during December. In addition, ALAN exposure in all duration groups decreased egg production and reduced hatchability from 61% ± 14% in the ALAN‐unexposed control group to 0% in the ALAN‐exposed birds. Disease severity was also found to increase in line with the duration of ALAN exposure. In captive M. undulatus, ALAN exposure was demonstrated to affect photoperiodic regulation with subsequent excess mass gain and reproduction impairment, and increased susceptibility to infections plausibly through duration dose‐dependent suppression of melatonin. To the best of our knowledge, this is the first study to demonstrate a possible association between acute bright ALAN of increasing duration and both natural development of infections as well as reproductive cessation in captive birds. Our findings could be used to improve breeding conditions of captive birds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.